MEDISON

Serial Number 79310660
Registration 7265162
700

Registration Progress

Application Filed
Nov 16, 2020
Under Examination
Approved for Publication
Oct 24, 2023
Published for Opposition
Oct 24, 2023
Registered
Jan 9, 2024

Trademark Image

MEDISON

Basic Information

Serial Number
79310660
Registration Number
7265162
Filing Date
November 16, 2020
Registration Date
January 9, 2024
Published for Opposition
October 24, 2023
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Jan 9, 2024
Registration
Registered
Classes
005 035

Rights Holder

MEDISON BIOTECH (1995) LTD.

99
Address
10 Hashiloach St.
Petach Tikva
IL

Ownership History

MEDISON BIOTECH (1995) LTD.

Original Applicant
99
IL

MEDISON BIOTECH (1995) LTD.

Owner at Publication
99
IL

MEDISON BIOTECH (1995) LTD.

Original Registrant
99
IL

Legal Representation

Attorney
Susan O. Goldsmith

USPTO Deadlines

Next Deadline
1618 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-01-09)
Due Date
January 09, 2030
Grace Period Ends
July 09, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

47 events
Date Code Type Description Documents
Nov 30, 2024 INNA R INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE Loading...
Nov 9, 2024 INPR P PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED Loading...
Apr 29, 2024 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Apr 16, 2024 NURC C NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED Loading...
Apr 9, 2024 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Apr 9, 2024 FIMP P FINAL DISPOSITION PROCESSED Loading...
Apr 9, 2024 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Mar 11, 2024 LIME I LIMITATION FROM THE IB EXAMINED AND ENTERED Loading...
Mar 8, 2024 COC. O CORRECTION UNDER SECTION 7 - PROCESSED Loading...
Jan 9, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jan 9, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jan 1, 2024 LIMG M LIMITATION OF GOODS RECEIVED FROM IB Loading...
Oct 24, 2023 GPNX P NOTIFICATION PROCESSED BY IB Loading...
Oct 24, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 24, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 4, 2023 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Oct 4, 2023 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Loading...
Oct 4, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 20, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 18, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Sep 18, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 18, 2023 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED Loading...
Mar 27, 2023 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Mar 27, 2023 GNFR O FINAL REFUSAL E-MAILED Loading...
Mar 27, 2023 CNFR R FINAL REFUSAL WRITTEN Loading...
Nov 15, 2022 RCCK S SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Loading...
Nov 7, 2022 OPNX P NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Loading...
Oct 19, 2022 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Oct 19, 2022 OPNR P NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Loading...
Jun 24, 2022 RCCK S SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Loading...
Jun 6, 2022 RCCK S SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Loading...
Nov 3, 2021 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Nov 3, 2021 GNSL S LETTER OF SUSPENSION E-MAILED Loading...
Nov 3, 2021 CNSL R SUSPENSION LETTER WRITTEN Loading...
Oct 29, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 29, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 29, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 13, 2021 RFNT P REFUSAL PROCESSED BY IB Loading...
May 26, 2021 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
May 26, 2021 RFRR P REFUSAL PROCESSED BY MPU Loading...
May 22, 2021 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
May 21, 2021 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 21, 2021 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
May 17, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
May 17, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
May 17, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 13, 2021 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Pharmaceuticals, namely, pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, allergies, anxiety, infection, dermatologic diseases, gastro-intestinal diseases, infectious diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases and medical preparations for the treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, allergies, anxiety, infections, dermatologic diseases, gastro-intestinal diseases, infectious diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; * none being generic or OTC pharmaceuticals or medical preparations; * vaccines; dietetic foods adapted for medical use
Class 035
Marketing, sales promotion for third parties, distribution of samples, and distribution of advertising materials all in the fields of pharmaceutical preparations, medical preparations, veterinary preparations, dietetic food and substances, medical and veterinary apparatus and equipment, and wholesale and retail store services featuring pharmaceutical preparations, medical preparations, veterinary preparations, dietetic food and substances, medical and veterinary apparatus and equipment * ; none of aforementioned services being in the field of generic pharmaceuticals or OTC product *

Additional Information

Design Mark
The mark consists of the stylized word MEDISON with the letters MEDIS and N in black and the letter "O" resembling a red ball partially covered by a white slightly curved band going bottom left to top right diagonally across it with the white band expanding in size from bottom to top.
Color Claim
The color(s) black, red and white is/are claimed as a feature of the mark.
Other
In the statement, Class 5 and 35, has been updated in accordance with the F-note dated 2/28/2024.

Classification

International Classes
005 035

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"MEDICINE"